FIGS just put up the kind of quarter that makes even seasoned healthcare investors sit up a little straighter in their ergonomic chairs. The direct‑to‑consumer scrubs innovator grew fourth‑quarter 2025 net revenues 33% year over year to a record 201.9 million dollars,…
InterGroup’s (INTG) latest results tell a tale of steady, brick‑and‑mortar progress—while San Francisco’s Opendoor Technologies (OPEN) adds a tech‑enabled twist to the real‑estate recovery narrative.
InterGroup Steps Back Into the Earnings Spotlight
The InterGroup Corporation (NASDAQ: INTG) reported a swing…
In a market that has spent three years asking whether iBuying is a feature or a business, Opendoor’s (OPEN) latest “Open House” suggests Opendoor 2.0 may finally be moving in. The company’s Q4 2025 results delivered faster growth in home acquisitions, improving…
FIGS, Inc. (NYSE: FIGS) has built a rare position in retail: a founder-led, direct-to-consumer brand that is simultaneously fashion-forward and mission-driven, with a loyal base of healthcare professionals who treat their scrubs almost like a uniformed fan club. The company designs technically…
Carvana’s (CVNA) latest earnings report delivered record sales and solid profits, but Wall Street still sent the stock to the repair bay for a valuation realignment.
Headline: Carvana’s Record Quarter Meets Wall Street’s Moodiness
Carvana closed 2025 with a quarter that many…
McDonald’s (MCD) has handled low-carb fads, kale revolutions, and the brief reign of cauliflower rice, but its newest rival comes with a prescription label and a co-pay. GLP-1 weight-loss medicines—from injectables like Eli Lilly’s (LLY) Mounjaro and Zepbound to the next wave…
US stocks extended last week’s relief rally on Monday, with megacap tech doing most of the heavy lifting while value names tried to remember what outperformance felt like. Investors spent the session toggling between AI euphoria, tariff anxiety and a yield curve…
Wall Street closed the week ending Feb. 6, 2026 looking a bit like a trader after a rough options expiry: bruised, but suddenly energetic once the bell rang on Friday. The Dow finally cracked the 50,000 mark in a more-than-1,000‑point sprint, while…
US stocks spent Thursday behaving like a slightly over-caffeinated, negative economist: plenty of motion & an overall negative conviction, as investors digested another wave of tech volatility, macro cross-currents, and a busy new-issue calendar heading into Friday’s jobs data. As evidence the…
In a fitting summary for the day, hard assets glittered, AI narratives wobbled, and Eli Lilly proved that in 2026, the market’s favorite growth story is just as likely to come from the medicine cabinet as from the data center. Broadly on…
